Pneumonia Testing Market Benefits from Molecular a..

创建了一篇新文章

4 d

Pneumonia Testing Market Benefits from Molecular and Point-of-Care Diagnostics | #healthcare

Pneumonia Testing Market Benefits from Molecular and Point-of-Care Diagnostics

The global market was valued at USD 2.27 billion in 2025 and is projected to grow from USD 2.44 billion in 2026 to USD 4.63 billion by 2035, registering a CAGR of 7.40% during the forecast period

喜欢

评论

分享